The biomedical giant best known for its Cologuard at-home colon cancer screening test reported a loss of $38.2 million, or $0.21 per share, on revenue of $708.7 million.

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

Exact Sciences shares plunged Wednesday after the maker of Cologuard reported widening losses and cut its outlook.

Researchers have discovered that semaglutide weight loss drugs like Ozempic may reduce the risk of early-onset colorectal cancer (CRC) in diabetes patients.

Brittany Pieniazek knew she had a chance of developing breast cancer. The Dyer resident’s mother and aunt had both been ...

What Are At-Home Colon Cancer Tests? The gold standard screening test for cancer in your colon or rectum, colorectal cancer, is a colonoscopy. This is done at a doctor's office under sedation ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults aged 45 years at average risk for colorectal cancer. The Food and Drug Administration (FDA) has approved the ...

Enter Cologuard, the at-home colon cancer screening test for people aged 45 and older. Perhaps best known by audiences for its cheeky approach to advertising, the Exact Sciences brand recently ...

The 41st annual Rotary Health Fair will take place on Saturday, Nov. 2 from 9 a.m-1 p.m. This year the fair will be held in a new location, the Christian Community Church on Bartlett Street in Homer.

New research suggests that omega-3 and omega-6 fatty acids, found in fish oil, may help prevent various cancers. A study of ...